Global Organ Preservation Markets 2022-2028: Analysis by Technique (Static Cold Storage (SCS) and Dynamic Cold Storage (DCS)) and Organ Type (Kidney, Liver, Lung, Heart, Other Organs) – ResearchAndMarkets .com | Nation/World

0

DUBLIN–(BUSINESS WIRE)–July 15, 2022–

The “Global Organ Preservation Market 2022-2028” report has been added to ResearchAndMarkets.comoffer.

The global organ preservation market is expected to grow at a substantial CAGR of 7.2% during the forecast period.

Organ preservation techniques maintain the functionality of organs for reuse in another human body through surgical procedures. Additionally, the growing awareness of organ transplants will further boost the growth of the organ preservation industry.

However, the risk of organ failure in the elderly and the lack of organ donors are hindering the growth of the market. Additionally, the development of robotic surgeries and technological advancements in organ preservation technology will emphasize the growth of organ preservation solutions in the near future.

The global organ preservation market is segmented on the basis of technique and organ type. Based on the technique, the market is further diversified into static cold storage (SCS) and dynamic cold storage (DCS). Based on organ type, the market is divided into kidney, liver, lung, heart and other organs.

Kidney preservation is expected to hold most of the market and the most widely used technique for kidney preservation is static cold storage (SCS). The kidney is stored on ice after being removed from the donor and then removed from the cooler at the time of implantation.

Geographically, the market is segmented into North America, Europe, Asia-Pacific, and Rest of the World. The North American region is expected to hold a leading position in the growth of the global organ preservation market. The market growth is attributed to funding programs and government support initiatives in the region to promote organ transplants. For example, according to the US Department of Health and Human Services, more than 40,000 transplants were performed in 2021.

The major companies serving the global organ preservation market are BioLife Solutions Inc., Essential Pharmaceuticals, LLC, Lineage Cell Therapeutics, Inc., Paragonix Technologies, Inc., and Waters Medical Systems, LLC.

Market players are significantly contributing to the growth of the market by adopting various strategies including mergers and acquisitions, partnerships, collaborations, financing, and new product launches to stay competitive in the market.

Main topics covered:

1. Summary of the report

  • Current industry analysis and growth potential outlook
  • Impact of COVID-19 on the global organ preservation market
  • Global Organ Preservation Market Recovery Scenario

1.1. Research methods and tools

1.2. Market Breakdown

1.2.1. By segments

1.2.2. By region

2. Overview and Market Overview

2.1. Report scope

2.2. Analyst overview and current market trends

2.2.1. Main conclusions

2.2.2. Recommendations

2.2.3. Conclusion

3. Competitive landscape

3.1. Key business analysis

3.2. BioLife Solutions Inc.

3.2.1. Insight

3.2.2. Financial analysis

3.2.3. SWOT analysis

3.2.4. RECENT DEVELOPMENTS

3.3. Essential Pharmaceuticals, LLC

3.3.1. Insight

3.3.2. Financial analysis

3.3.3. SWOT analysis

3.3.4. RECENT DEVELOPMENTS

3.4. Lineage Cell Therapeutics, Inc.

3.4.1. Insight

3.4.2. Financial analysis

3.4.3. SWOT analysis

3.4.4. RECENT DEVELOPMENTS

3.5. Paragonix Technologies, Inc.

3.5.1. Insight

3.5.2. Financial analysis

3.5.3. SWOT analysis

3.5.4. RECENT DEVELOPMENTS

3.6. Waters Medical Systems, LLC

3.6.1. Insight

3.6.2. Financial analysis

3.6.3. SWOT analysis

3.6.4. RECENT DEVELOPMENTS

3.7. Key strategic analysis

3.8. Impact of Covid-19 on key players

4. Market segmentation

4.1. Global Organ Preservation Market by Technique

4.1.1. Static cold storage technique (SCS)

4.1.2. Dynamic Cold Storage (DCS) Technique

4.2. Global Organ Preservation Market by Organ Type

4.2.1. Kidney

4.2.2. Liver

4.2.3. Lung

4.2.4. Heart

4.2.5. Other organs (pancreas, intestine)

5. Regional analysis

5.1. North America

5.1.1. WE

5.1.2. Canada

5.2. Europe

5.2.1. UK

5.2.2. Germany

5.2.3. Italy

5.2.4. Spain

5.2.5. France

5.2.6. The rest of Europe

5.3. Asia Pacific

5.3.1. China

5.3.2. India

5.3.3. Japan

5.3.4. South Korea

5.3.5. Rest of Asia-Pacific

5.4. Rest of the world

6. Company Profile

6.1. 21st Century Medicine, Inc.

6.2. BioLife Solutions Inc.

6.3. Bridge to Life Ltd.

6.4. CryoLife, Inc.

6.5. Essential Pharmaceuticals, LLC

6.6. Lifeline Scientific, Inc.

6.7. Lineage Cell Therapeutics, Inc.

6.8. Organ Assist Products BV (XVIVO Perfusion AB)

6.9. Organ Recovery Systems, Inc.

6.10. OrganOx Ltd.

6.11. Paragonix Technologies, Inc.

6.12. Preservation Solutions, Inc.

6.13. TransMedics, Inc.

6.14. Waters Medical Systems, LLC

For more information on this report, visit https://www.researchandmarkets.com/r/gwnqin

Show source version on businesswire.com:https://www.businesswire.com/news/home/20220715005165/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Officer

[email protected]

For EST business hours, call 1-917-300-0470

For US/CAN call toll free 1-800-526-8630

For GMT office hours call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY

SOURCE: Research and Markets

Copyright BusinessWire 2022.

PUBLISHED: 07/15/2022 05:31 / DISK: 07/15/2022 05:32

http://www.businesswire.com/news/home/20220715005165/en

Share.

About Author

Comments are closed.